Pharmaceutical Product Development.

PositionEastern

Wilmington-based contract-research organization Pharmaceutical Product Development named Pfizer executive David Simmons chairman and CEO. He replaces Raymond Hill, who left in December after New York City-based asset manager The Carlyle Group and San Francisco-based private-equity group...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT